(Circulation. 1996;94:1682-1689.)
© 1996 American Heart Association, Inc.
Articles |
Fluid Flow Inhibits Endothelial Adhesiveness
Nitric Oxide and Transcriptional Regulation of VCAM-1
the Falk Cardiovascular Research Center, Stanford, Calif.
Correspondence to John P. Cooke, MD, PhD, Falk Cardiovascular Research Center, 300 Pasteur Dr, Stanford, CA 94305-5246.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background In the arterial tree, regions exposed to reduced shear stress (low and/or disturbed flow) are predisposed to atherogenesis. Fluid flow is a potent stimulus for the release of endothelium-derived nitric oxide (NO). Because NO inhibits monocyte–endothelial cell interaction, we speculated that the effects of flow in inhibiting atherogenesis might be mediated in part by NO.
Methods and Results Confluent monolayers of human aortic endothelial cells were exposed to static or fluid flow conditions for 4 hours. The medium was replaced, and cells were then incubated with native LDL (50 µg/mL), oxidized LDL (30 µg/mL), or lipopolysaccharide (LPS) (10 ng/mL) + tumor necrosis factor-
(TNF-) (10 U/mL) for an additional 4 hours. Functional binding assays using THP-1 monocytes were then performed. Superoxide production by human aortic endothelial cells was monitored by lucigenin chemiluminescence, and expression of the adhesion molecules vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 were quantified by flow cytometry. Whereas native LDL had little effect, incubation with either oxidized LDL or LPS/TNF- significantly increased superoxide production, nuclear factor-
B activity, VCAM-1 expression, and endothelial adhesiveness for monocytes. Previous exposure to fluid flow inhibited these sequelae of exposure to cytokines or oxidized lipoprotein. The effect of fluid flow appears to be due in part to shear-induced release of NO, because coincubation with nitro-L-arginine completely abolished these effects of flow. Furthermore, the NO donor PAPA-NONOate and 8-Br-cGMP (but not 8-Br-cAMP) mimicked the effects of flow.
Conclusions Previous exposure to fluid flow decreased cytokine- or lipoprotein-stimulated endothelial cell superoxide production, VCAM-1 expression, and monocyte binding; the effects of flow appear to be due to NO. Flow-mediated NO-dependent regulation of oxidant-responsive transcription may influence the site of a lesion.
Key Words: blood flow • endothelium-derived factors • adhesion molecules • atherosclerosis • free radicals
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The distribution of atherosclerotic lesions throughout the vascular tree is nonuniform. As early as the 19th century, the great pathologists Rokitansky1 and Virchow2 independently speculated that this nonuniformity was due to local alterations in hemodynamic forces impinging on the vascular tree. Indeed, at sites vulnerable to plaque formation—bends, branches, and bifurcations—unidirectional laminar flow is disturbed, with areas of recirculation characterized by low and fluctuating shear stress.3 4 5 6 7 In these regions of low shear stress, the vulnerability to plaque formation may be a result of enhanced monocyte binding. Adhesive interactions between leukocytes in the vessel wall are less likely to be disrupted under conditions of low shear stress. Furthermore, experimental reductions of blood flow enhance endothelial adhesiveness for monocytes.8 9 This may be in part because low-shear regions exhibit enhanced permeability to macromolecules, including LDL10 11 ; accumulation and modification of LDL in the vessel wall could trigger a cascade of events leading to changes in the chemotactic and adhesive properties of the endothelium.10 11
Tractive forces of fluid flow also modulate the gene expression of endothelial adhesion molecules and cytokines that participate in monocyte binding. In the New Zealand White rabbit, an adhesion molecule homologous to the human VCAM-1 is upregulated by hypercholesterolemia and is expressed at sites of early lesion formation.12 13 The expression of VCAM-1 in a murine endothelial cell line is reduced by 75% after 24 hours of exposure to laminar fluid flow.14 The expression of VCAM-1 is regulated in part by oxidant-responsive transcriptional activation.15 Oxidized LDL and cytokines induce the expression of VCAM-1 via a transcriptional pathway modulated by NF-B; this NF-B–mediated gene expression can be abrogated by antioxidants.15
Flow is also a potent stimulus for endothelial elaboration of NO.16 17 18 Recent evidence indicates that in addition to its role as a potent vasodilator, NO downregulates oxidative enzyme activity and reduces intracellular oxidative stress.19 20 We therefore propose that flow inhibits VCAM-1 expression by triggering the release of endothelium-derived NO and thereby inhibiting oxidant-responsive transcriptional activation. Accordingly, in this investigation we tested the hypothesis that flow inhibits, in an NO-dependent manner, the effects of oxidized LDL and cytokines in inducing endothelial oxidative stress, to activate NF-B–mediated expression of VCAM-1, and to increase endothelial adhesiveness for monocytes.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Endothelial Cell Culture
HAECs (Clonetics), passages 3 through 6, were grown to confluence in endothelial growth medium (Clonetics) on 60-mm culture dishes in a 5% CO2 atmosphere at 37°C. Endothelial growth medium contains epidermal growth factor (10 ng/mL), hydrocortisone (1 µg/mL), bovine brain extract (10 µg/mL), FCS (2%), gentamicin (50 µg/mL), and amphotericin-B (50 ng/mL). These cells have a normal cobblestone phenotype and test positive for factor VIII antigen. THP-1 (ATCC) was cultured in RPMI medium (Life Technologies) containing 10% FCS. Viability of THP-1 cells, as determined by trypan blue exclusion, was >95%.
Fluid Flow
Confluent monolayers were placed in serum-free medium for 1 hour and then exposed to static conditions or flow. Flow was induced by placement of confluent 60-mm culture dishes on a mixing table (Thermylene) rotating at 120 rpm for 4 hours. Compared with the well-defined cone-plate viscometer,21 22 this technique induces qualitatively similar changes in cell alignment, NOx production, and NOS mRNA transcription.23 Fluid flow with the mixing table caused endothelial cells to produce levels of NOx comparable to those attained by the cone-plate viscometer generating a shear stress of 12 dynes/cm2. After 4 hours of flow, NOx levels in the conditioned medium increased by 105% compared with static controls.23
In some experiments, cells were treated with the NOS inhibitors L-NA (100 µmol/L), 8-Br-cGMP (100 µmol/L), or 8-Br-cAMP (100 µmol/L) or the NO donor PAPA-NONOate (100 µmol/L) (Caymen Chemical) in static conditions. PAPA-NONOate is a stable NO donor that dissociates to the free amine and NO according to first-order kinetics at physiological pH (pH 7.4) and has a half-life of 72 minutes. All drugs were incubated with the endothelial cells for 4 hours before addition of lipoproteins or cytokines; then the drugs were removed with fresh HBSS medium. After 4 hours of either flow or static conditions, cells were placed in static conditions and exposed to native LDL (50 µg/mL), oxLDL (30 µg/mL), or LPS (10 ng/mL)+TNF- (10 U/mL) (Sigma) for 4 hours.
Lipoprotein Preparation
LDL was isolated by density gradient ultracentrifugation of normal human plasma collected in EDTA (1 mg/mL). The protein fraction was quantified by Lowry assay with BSA as standard. oxLDL was prepared by incubation of LDL (100 µg/mL) in 2 mL F-10 medium containing CuSO4 (10 µmol/L) in a 37°C incubator for 24 hours. BHT was then added to halt the oxidation process. The extent of oxidation was monitored by measurement of TBARS at 550 Å as previously described. Copper oxidation of LDL routinely produced 40 to 60 nmol TBARS/mg LDL.
Adhesion Assay
Monocyte adhesion assays were performed as previously described.23 Briefly, HAECs exposed to the above conditions were washed with HBSS (Irvine Scientific) containing (in mmol/L) CaCl2 2, MgCl2 2, and HEPES 20. Culture dishes were then placed on a rocking platform, and THP-1 cells were incubated with HAECs for 30 minutes, with dishes rotated 120° clockwise every 10 minutes to ensure even distribution of cells. Medium was aspirated and replaced with fresh HBSS to remove nonadherent cells. After a second washing, dishes were returned to the rocker platform for an additional 5 minutes. Medium was again aspirated and replaced with HBSS containing 2% glutaraldehyde. After overnight fixation, adherent cells were quantified by light microscopy.
Flow Cytometry
To detect changes in the expression of endothelial glycoprotein adhesion molecules, we performed flow cytometry using specific monoclonal antibodies to VCAM-1 and ICAM-1. Confluent HAECs were exposed to shear stress or static conditions for 4 hours and then one of the described conditions for an additional 4 hours. Cells were gently detached with 5 mmol/L EDTA. Subsequently, 10% FCS was added to the cell suspension, and the cells were processed for fluorescence analysis by a highly modified dual-laser FACS IV (Becton Dickinson). Nonviable cells were detected by the technique of propidium iodide (1 µg/mL) incorporation. Propidium iodide–positive cells were excluded by electronic gating. In general, viability was judged to be >95%. To assess the expression of endothelial adhesion molecules, cell suspensions (2x106/mL) were incubated for 25 minutes on ice with anti-human VCAM-1 monoclonal antibody (1:100) (Endogen, Inc), anti–human ICAM-1 monoclonal antibody (Genzyme), or an isotype-matched control antibody. Nonspecific binding was blocked by incubation of the cells with human serum. Subsequently, the cells were stained with goat anti-mouse monoclonal antibody conjugated with Texas Red (0.5 mg/mL) (Molecular Probes).
Superoxide Production
Superoxide anion production by HAECs was monitored by modification of the method previously reported by Pagano et al.24 After undergoing the described protocols, HAECs were detached from culture dishes with EDTA, washed with PBS, and resuspended in HBSS containing lucigenin (250 µmol/L). In some experiments, the copper-zinc SOD inhibitor diethyldithiocarbamate (10 mmol/L) was added to enhance superoxide production. Superoxide was monitored in a Turner Designs luminometer for 1 minute with 30-second delay. The relative specificity of lucigenin-induced chemiluminescence by superoxide anion is demonstrated by the lack of effect of scavengers of hydrogen peroxide and by the potent effect of 4,5-dihydroxy-1,3-benzene disulfonic acid (100 µmol/L), an intracellular scavenger of superoxide, in blocking the signal.
Electrophoretic Mobility Shift Assay
Nuclear extracts were prepared as described by Dignam et al.25 Cells from the appropriate conditions were harvested, centrifuged to pellet cells, and washed in ice-cold PBS. The remaining steps were performed on ice or at 4°C. Cells were resuspended in buffer A (in mmol/L: PMSF 0.5, HEPES 10 [pH 7.8], MgCl2 1.5, KCl 10, and DTT 0.5) containing 0.1% Nonidet P-40 and disrupted in a tight-fitting Dounce homogenizer. Nuclei were then pelleted by centrifugation (25 000g, 20 minutes, 4°C). Crude nuclei were resuspended in buffer C (in mmol/L: HEPES 20 [pH 7.8], NaCl2 0.42, MgCl2 1.5, EDTA 0.2, DTT 0.5, and PMSF 0.5; 25 vol% glycerol) and incubated on ice for 30 minutes. The mixture was then spun at 25 000g for 20 minutes at 4°C, the supernatant was collected, and protein was quantified. Nuclear proteins were stored at -85°C until gel shift assay. Binding reactions were carried out by mixing nuclear proteins with a double-stranded oligonucleotide corresponding to the published NF-B–binding domain (5'-AGT TGA GGG GAC TTT CCC AGG C). Reactions were performed with 32P-labeled DNA oligonucleotide in the presence of (in mmol/L) MgCl2 1, EDTA 0.5, DTT 0.5, NaCl 50, and Tris-HCl 10 (pH 7.5) and 0.05 µg/mL polydeoxyinosinic-deoxycytidylic acid in 20 vol% glycerol. Samples were separated on a 4% nondenaturing polyacrylamide gel and exposed to x-ray film overnight.
Data Analysis
Data are expressed as mean±SEM. Comparisons of multiple means were made by ANOVA followed by a Fisher's protected least significant difference test. A value of P<.05 was accepted as statistically significant.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Effect of Flow on Endothelial Adhesiveness
Incubation of HAECs with native LDL for 4 hours had little effect on endothelial adhesiveness for THP-1 monocytes compared with control cells not exposed to lipoproteins (Fig 1
). In contrast, exposure of HAECs to oxLDL (50 µg/mL) increased THP-1 binding to HAECs by 58±14% compared with control cells (P<.05) (Fig 2). In either case, previous exposure to either flow or the NO donor PAPA-NONOate markedly reduced monocyte binding. The cGMP analogue 8-Br-cGMP had no significant effect on endothelial adhesiveness in native LDL–treated cells, whereas it had a modest effect on monocyte–endothelial cell interactions induced by oxLDL.
|
|
Fig 3 illustrates the more potent effect of LPS and the cytokine TNF- to increase monocyte adhesion (210±18%) compared with cells treated with vehicle (P<.01). Prior exposure to flow protected the endothelial cells from this agonist-induced adhesion (94±12% of control; P<.01 from static+LPS/TNF-). The NO donor PAPA-NONOate mimicked the effect of flow; in contrast, 8-Br-cGMP had very little effect. Incubation of HAECs with the cAMP analogue 8-Br-cAMP (100 µmol/L) for 4 hours augmented monocyte binding induced by oxLDL or cytokines (data not shown).
|
Effect of Flow on Endothelial Adhesion Molecules
To determine whether flow exerted its effect on monocyte binding by altering the expression of endothelial adhesion molecules, we performed flow cytometric analysis of HAECs for ICAM-1 and VCAM-1 that had been stimulated with oxLDL or LPS+TNF-. As illustrated in the representative tracing shown in Fig 4, oxLDL (30 µg/mL) increased expression of ICAM-1 in HAECs after 4 hours, as did the combination of LPS+TNF- over basal expression. Previous exposure to flow had no effect on the surface expression of ICAM-1 to either agonist. Likewise, the NO donor PAPA-NONOate in static conditions did not affect ICAM-1 levels.
|
Flow cytometric analysis revealed that HAECs express lower levels of VCAM-1 under basal conditions than of ICAM-1 (Fig 5). Exposure of endothelial cells to oxLDL (P<.05) or LPS/TNF- (P<.01) markedly elevated VCAM-1 expression compared with cells exposed to vehicle. Induced expression of VCAM-1 by both oxLDL and cytokines was significantly suppressed by previous exposure to flow. The effect of flow is largely due to shear stress–induced NO production, since exposure of HAECs to L-NA (1x10-4) abrogated the effect of flow on VCAM-1 (Fig 6). Furthermore, the effect of flow was mimicked by the NO donor PAPA-NONOate in the absence of shear stress (Fig 6). Data from five separate experiments are summarized in Table 1.
|
|
|
Effect of Flow on Oxidant-Sensitive Transcription
VCAM-1 has been shown to be an oxidant-responsive gene in endothelial cells. Therefore, to characterize the oxidative stress of endothelial cells exposed to oxidized LDL or cytokines, we monitored endothelial superoxide anion production using lucigenin chemiluminescence. Whereas native LDL had minimal effect, oxLDL significantly increased endothelial superoxide production. LPS+TNF caused a further increase in the generation of superoxide anion (Table 2). Previous exposure to flow opposed the effect of oxidized LDL or cytokines in increasing endothelial superoxide anion generation. The reduction in superoxide anion appears to be a sustained effect of NO, since media containing PAPA-NONOate or conditioned media after shear stress were removed before superoxide measurements. The addition of the NOS inhibitor L-NA 15 minutes before superoxide measurements had no effect on the shear stress– or NO donor–mediated reduction in superoxide production. Therefore, it is unlikely that the effect of NO in this system is simply due to a scavenging of superoxide anions but rather to a more chronic effect on the endothelial generation of superoxide anion.
|
Molecular cloning of VCAM-1 has provided evidence for NF-B–binding domains in the promoter region of this gene. Since NF-B has been reported to respond to oxidative stress, we examined whether NO may have an effect on NF-B activity. Nuclear extracts from HAECs were isolated, and gel-shift analysis was performed with an oligonucleotide containing the putative NF-B binding site. As shown in Fig 7, both oxLDL (lane 2) and LPS+TNF- (lane 5) induced activation of NF-B. This effect was greatly reduced in cells previously exposed to flow (lanes 3 and 6). Exposure of HAECs to PAPA-NONOate in static conditions had a similar effect of inhibiting NF-B activity. Furthermore, the effect of flow in inhibiting NF-B activation was mimicked by PAPA-NONOate in the absence of shear stress.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The salient findings of this study are that (1) oxidized LDL or cytokines induce endothelial elaboration of superoxide anion, elevate NF-
B binding activity, augment VCAM-1 expression, and increase endothelial adhesiveness for monocytes; (2) prior exposure of the endothelial cells to flow abrogates these lipid- or cytokine-induced alterations; (3) the effects of flow appear to be partially mediated by NO, since they are blocked by NOS antagonists and mimicked by NO donors; and (4) the effects of NO are likely to be mediated in part by non-cGMP pathways, because 8-Br-cGMP only partially mimicked the effects of flow on NO donors. Oxidant stress may play a central role in precipitating endothelial cell–monocyte interaction in atherogenesis. Recent evidence indicates the existence of oxidant-responsive genes encoding proteins that modulate endothelial adhesiveness.15 26 We hypothesized that flow-mediated NO-dependent regulation of intracellular oxidative enzyme activity would chronically inhibit oxidant-responsive transcriptional pathways that regulate endothelial adhesiveness. The present investigation confirms this hypothesis and suggests a mechanism by which hemodynamic forces may influence the site of a lesion.
Early in the course of atherogenesis, hypercholesterolemia induces an alteration in endothelial function. After 8 weeks of hypercholesterolemia, there is a marked increase in superoxide anion generation by the endothelium of the rabbit thoracic aorta.27 Endothelial generation of superoxide anion may promote adhesion. Leukocyte adherence and emigration in cat mesenteric venules are enhanced by LPS, an effect that is significantly reduced by administration of SOD.28 Injection of human oxLDL elicits rolling and adhesion of circulating leukocytes in arterioles and postcapillary venules of hamsters.29 This adhesion is significantly attenuated when the animals are pretreated with bovine copper-zinc-SOD or heparin to release extracellular SOD. Increasing evidence indicates that endothelium-derived NO may act as an endogenous regulator of oxidative enzyme activity. In normocholesterolemic rabbit thoracic aorta, there is a basal production of superoxide anion by nonendothelial cells.24 Exogenous NO donors significantly reduce the generation of superoxide anion. Administration of an NO precursor, benzoyl-L-arginine ethyl ester, decreases alloxan-stimulated superoxide production by rabbit aorta, an effect that is reversed by the NOS antagonist NG-monomethyl-L-arginine.30
The mechanism by which NO reduces oxidative stress remains undefined. It is unlikely that NO exerts this effect by directly scavenging superoxide anion, because the product of this reaction, peroxynitrate, is a highly reactive free radical that itself can initiate lipid peroxidation.31 However, it is possible that NO reacts directly with lipid peroxyl radicals, thereby disrupting the chain of autocatalytic reactions involved in the oxidation of intracellular lipid. Indeed, NO donors inhibit copper-catalyzed oxidation of LDL cholesterol in vitro.32 Second, NO may directly inhibit the generation of oxygen-derived free radicals by oxidative enzymes. By virtue of its ability to nitrosylate proteins, NO may alter their behavior or activity. Clancy and colleagues19 found that when neutrophils are exposed to NO, their ability to generate superoxide anion is limited, apparently because of a direct effect of NO on the multimeric oxidative enzyme NADPH oxygenase, since prior incubation of its membrane-bound component with NO inhibits the assembly (and activation) of the enzyme. These observations are concordant with the observation of Yates and colleagues,33 who found that autocrine NO regulates macrophage oxidation of LDL cholesterol. When mouse peritoneal macrophages were exposed to TNF- and interferon-
to induce NO elaboration, their ability to oxidize human LDL cholesterol was reduced; this effect was reversed by an antagonist of NOS. Similarly, in the present study, the effect of flow in reducing superoxide anion generation by endothelial cells was NO dependent. Taken together, these studies indicate that NO reduces oxidant stress. The critical role of NO in modulating endothelial generation of oxygen-derived free radicals has also been demonstrated by Niu and coworkers,20 who used intracellular fluorophores responsive to intracellular increase in oxygen-derived free radicals to demonstrate that antagonists of NOS precipitated oxidative stress. Similarly, in the present study, the effect of flow in reducing superoxide anion generation by endothelial cells was largely NO dependent.
The effect of NO in reducing the generation of reactive oxygen species may explain its repression of NF-B–mediated gene expression. Antioxidants such as n-acetylcysteine and pyrrolidine dithiocarbamate are known to inhibit the dissociation of NF-B from its inhibitor, I-B.34 35 In cultured human umbilical vein endothelial cells, interleukin-1–induced expression of VCAM-1 is selectively antagonized by exposure of the cells to pyrrolidine dithiocarbamate.15 NO donors mimic the effect of antioxidants in suppressing NF-B–mediated gene expression. The activation of NF-B by TNF- in cultured human saphenous vein endothelial cells was blocked by exogenous NO, whereas NO donors had little effect on other nuclear binding proteins (activator protein–1 and GATA).36 Immunoprecipitation studies indicated that exogenous NO stabilized the NF-B/I-B complex. Moreover, exogenous NO enhanced the transcription of I-B but not that of the NF-B subunits p50 and p65. These observations most likely explain previous findings that exogenous NO donors inhibit interleukin-1–stimulated VCAM-1 expression and monocyte adhesion.37
We found that the effects of flow in inhibiting NF-B–mediated VCAM-1 expression and endothelial adhesiveness could be accounted for by elaboration of endogenous NO. The effects of flow are mimicked by NO donors, whereas the cGMP analogue had only a partial effect. This implies that NO exerts its effects in part by cGMP-independent pathways, in agreement with the above studies. Similarly, Zeiher et al38 found that cGMP analogues did not mimic the effect of exogenous NO donors in inhibiting NF-B activity and monocyte chemotactic protein-1 expression by NO. This is in contrast to the in vivo work of Kurose and colleagues,39 who found that the enhanced adhesion of leukocytes to vessels perfused by nitro-L-arginine methyl ester could be completely reversed by 8-Br-cGMP. This discrepancy may be due to other effects of the cGMP analogue in vivo (eg, vasodilation with attendant increases in flow or direct effects on monocyte adhesive proteins). However, Kuchan and Frangos40 have also demonstrated that the negative regulation of endothelin-1 by flow is dependent on NO and is mimicked by 8-Br-cGMP. The mechanism of action may differ from the present study, since the endothelin promoter does not appear to contain an NF-B consensus sequence.
The effect of NO on NF-B and I-B, however, may not totally explain the effects of flow on VCAM-1 expression or monocyte binding. VCAM-1 promoter activity has been demonstrated to be under the complex control of both stimulatory and inhibitory transactivating factors. Moreover, deletion analysis has demonstrated that NF-B–binding activity is important for optimal stimulation of the VCAM-1 promoter but is not essential for VCAM-1 transcription. In addition, NF-B activity does not fully explain the effect on adhesion molecule expression, since ICAM-1 expression was only minimally affected by NO. Other nuclear binding proteins may dominate in cytokine- or lipid-induced ICAM-1 expression. Furthermore, the ICAM-1 promoter contains the SSRE GAGACC first defined by Resnick et al.41 This SSRE may be responsible for the positive regulation by shear stress of ICAM-1 that we observed in this study. This same SSRE is found in the promoter region of a number of genes regulated by flow, including endothelial cell NOS.42 43 Therefore, mechanisms independent of NO may contribute to the effects of flow on endothelial adhesiveness. For example, flow enhances the release of prostacyclin, which might also contribute to the flow-induced inhibition of endothelial adhesion.44 45
It is interesting to note that the effects of fluid flow seen in the present study persist even after cessation of flow. In contrast, NO production quickly falls to baseline levels after cessation of fluid flow. Kanai et al46 used a porphyrinic microsensor to detect NO elaborated by cultured endothelial cells in response to fluid flow. With cessation of the flow stimulus, NO concentration in the conditioned medium declined at a rate that would be predicted by oxidative degradation of the NO released into the medium during flow. This observation suggests that NO elaboration ceases instantaneously with discontinuation of the flow stimulus. However, in the present study, the effect on endothelial adhesiveness of flow-induced NO release persisted for at least 4 hours. We speculate that this persistent effect may be due to the inactivation by NO of oxidative enzyme activity, which probably has a long time constant, given the extraordinary affinity of NO for heme proteins.
Flow-stimulated NO also has acute effects on monocyte–endothelial cell interaction, as well as the more chronic effects on gene expression. Monocyte adherence to endothelial cells in culture is inhibited by administration of NO with a time course that implies an effect of adhesion pathways on signal transduction.44 We have also shown that the adherence of monocytoid cells to bovine aortic endothelial cells is inhibited by brief (ie, 15-minute) exposure to NO donors or increases in endogenous NO in the absence of any changes in VCAM-1 or ICAM-1 expression.23 The acute and chronic effects of NO on endothelial adhesiveness may play an important role in atherogenesis. The effect of habitual exercise in inhibiting atherosclerotic lesion formation47 48 may be due in part to the effect of exercise in enhancing the vascular expression of endothelial cell NOS and elaboration of NO.49 Similarly, the predisposition to lesion formation at sites of branching may be due in part to the reduced elaboration of NO at these sites.50 This speculation is supported by our previous observations that enhancement of vascular NO activity in the hypercholesterolemic rabbit inhibits endothelial adhesiveness for monocytes and reduces lesion formation.51 52 53 In contrast, chronic administration of NOS antagonists enhances endothelial adhesiveness and increases monocyte accumulation in the vessel wall.53 54 55 Similar effects of NO on endothelial cell–neutrophil interactions have been observed in hypercholesterolemia.56 Taken together, these studies implicate NO as an endogenous antiatherogenic molecule, which exerts its effects in part via its modulation of oxidant-responsive transcriptional pathways.
To summarize, this investigation reveals that exposure to flow decreases cytokine- and lipoprotein-stimulated endothelial cell superoxide production, VCAM-1 expression, and monocyte binding. The effects of flow are abolished by the NOS antagonist L-NA, whereas in the absence of flow, an exogenous NO donor mimics the effect of endothelial shear stress. Flow-mediated NO-dependent regulation of oxidant-responsive transcription may be a critical determinant of the site of a lesion.
|
Selected Abbreviations and Acronyms |
|---|
|
|
Acknowledgments |
|---|
This work was supported in part by a grant from the National Heart, Lung, and Blood Institute (1R01-HL-58638) and was done during the tenure of a Grant-in-Aid Award from the American Heart Association and Sanofi Winthrop. Dr Tsao is the recipient of a National Service Research Award (1F32-HL-08779). Dr Cooke is a recipient of the Vascular Academic Award from the National Heart, Lung, and Blood Institute (1K07-HC-02660) and is an Established Investigator of the American Heart Association. The authors appreciate the advice and assistance of Jack Sun and Susan Alpert (flow cytometry experiments), Jay Oakes and Andrew Weyrich (electrophoretic mobility shift assay), and Mike Gillette (manuscript preparation).
Received August 21, 1995; revision received April 11, 1996; accepted April 16, 1996.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Rokitansky C. The pathological anatomy of the organs of respiration and circulation. In: Day GE, trans. A Manual of Pathological Anatomy. London, UK: Sydenham Society; 1952;vol 4.
2. Virchow R; Clance F, trans. Cellular Pathology as Based Upon Physiological and Pathological Histology. London, UK: Churchill; 1860.
3. Montenegro MR, Eggen DA. Topography of atherosclerosis in the coronary arteries. Lab Invest. 1968;18:586-593.[Medline] [Order article via Infotrieve]
4. Sinzinger H, Siberbauer K, Auerswald W. Quantitative investigation of sudanophilic lesions around the aortic ostia of human fetuses, newborns and children. Blood Vessels. 1980;17:44-52.[Medline] [Order article via Infotrieve]
5. Cornhill JF, Barrett WA, Herderick EE, Mahley RW, Fry DF. Topographic study of sudanophilic lesions in cholesterol-fed minipigs by image analysis. Atherosclerosis. 1985;5:415-426.
6. Glagov S, Zarins C, Giddens DP, Ku DN. Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med. 1988;112:1018-1031.[Medline] [Order article via Infotrieve]
7.
Asakura T, Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ Res. 1990;66:1045-1066.
8. Walpola PL, Gottlieb AI, Langille BL. Monocyte adhesion and changes in endothelial cell number, morphology, and F-actin distribution elicited by low shear stress in vivo. Am J Pathol. 1993;142:1392-1400.[Abstract]
9.
Walpola PL, Gottlieb AI, Cybulsky MI, Langille BL. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler Thromb Vasc Biol. 1995;15:2-10.
10.
Schwenke DE, Carew TE. Quantification in vivo of increased LDL content and rate of LDL degradation in normal rabbit aorta occurring at sites susceptible to early atherosclerotic lesions. Circ Res. 1988;62:699-710.
11.
Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation. 1995;91:2488-2496.
12.
Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251:788-791.
13.
Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb. 1993;13:197-204.
14. Ohtsuka A, Ando J, Korenaga R, Kamiya A, Toyama-Sorimachi N, Miyasaka M. The effect of flow on the expression of vascular adhesion molecule-1 by cultured mouse endothelial cells. Biochem Biophys Res Commun. 1993;193:303-310.[Medline] [Order article via Infotrieve]
15. Marui N, Offerman MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993;92:1866-1874.
16.
Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increase flow in vivo. Hypertension. 1986;8:37-44.
17. Cooke JP, Stamler JS, Andon N, Davies PR, Loscalzo J. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol. 1990;(Heart Circ Physiol 28):H804-H812.
18. Cooke JP, Rossitch E, Andon N, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest. 1991;88:1663-1671.
19. Clancy RM, Leszczynska P, Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on NADPH oxidase. J Clin Invest. 1992;90:1116-1121.
20.
Niu XF, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res. 1994;74:1133-1140.
21. Bussolari SR, Dewey CF Jr, Gimbrone MA Jr. Apparatus for subjecting living cells to fluid shear stress. Rev Sci Instrum. 1982;53:1851-1854.[Medline] [Order article via Infotrieve]
22.
Ohno M, Gibbons GH, Dzau VJ, Cooke JP. Shear stress elevates endothelial cGMP: role of a potassium channel and G protein coupling. Circulation. 1993;88:193-197.
23.
Tsao PS, Lewis NP, Alpert SA, Cooke JP. Fluid flow decreases endothelial adhesiveness for monocytes: role of nitric oxide. Circulation. 1995;92:3513-3519.
24.
Pagano PJ, Tornheim K, Cohen RA. Superoxide anion production by rabbit thoracic aorta: effect of endothelium-derived nitric oxide. Am J Physiol. 1993;265:H707-H712.
25.
Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11:1475-1489.
26.
Weber C, Erl W, Pietsch A, Strobel M, Ziegler-Heitbrock HW, Weber PC. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb. 1994;14:1665-1673.
27. Ohara Y, Petersen TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993;91:2546-2551.
28. Harris NR, Russell JM, Granger DN. Mediators of endotoxin-induced leukocyte adhesion in mesenteric postcapillary venules. Circ Shock. 1994;43:155-160.[Medline] [Order article via Infotrieve]
29.
Lehr HA, Becker M, Marklund SL, Hubner C, Arfors KE, Kohlschutter A, Messmer K. Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo. Arterioscler Thromb. 1992;12:824-829.
30.
Heim KF, Thomas G, Ramwell PW. Effect of substituted arginine compounds on superoxide production in the rabbit aorta. J Pharmacol Exp Ther. 1991;257:1130-1135.
31. Beckman JS, Crow JP. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans. 1993;21:330-334.[Medline] [Order article via Infotrieve]
32. Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide: potential role in atherogenesis. FEBS Lett. 1993;334:170-174.[Medline] [Order article via Infotrieve]
33. Yates MT, Lambert LE, Whitten JP, McDonald I, Mano M, Ku G, Mao SJT. A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages. FEBS Lett. 1992;309:135-138.[Medline] [Order article via Infotrieve]
34. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle PA. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature. 1993;365:182-185.[Medline] [Order article via Infotrieve]
35.
Devary Y, Rosette C, DiDonato JA, Karin M. NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science. 1993;261:1442-1445.
36.
Peng HB, Libby P, Liao JK. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem. 1995;270:14214-14219.
37. DeCaterina R, Libby P, Peng H-B, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. J Clin Invest. 1995;96:60-68.
38.
Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res. 1995;76:980-986.
39. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, Miyasaka M, Granger DN. Inhibition of nitric oxide production: mechanisms of vascular albumin leakage. Circ Res. 1993;73:164-171.[Abstract]
40.
Kuchan MJ, Frangos JA. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol. 1993;264:H150-H156.
41.
Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF Jr, Gimbrone MA Jr. Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci U S A. 1993;90:4591-4595.
42.
Marsden PA, Heng HHQ, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui L, Schappert KT. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase. J Biol Chem. 1993;268:17478-17488.
43. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest. 1992;90:2090-2096.
44.
Frangos JA, Eskin SG, Mcintire LV, Ives CL. Flow effects prostacyclin production of cultured human endothelial cells. Science. 1985;227:1477-1479.
45.
Bath PM, Hassall DG, Gladwin AM, Palmer RMJ, Martin JF. Nitric oxide and prostacyclin: divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb. 1991;11:254-260.
46.
Kanai AJ, Strauss HC, Truskey GA, Crews AL, Grunfeld S, Malinski T. Shear stress induces ATP-independent transient nitric oxide release from vascular endothelial cells, measured directly with a porphyrinic microsensor. Circ Res. 1995;77:284-293.
47. Richard MJ, Davis LD, Jacobson NL. The domestic goat: a useful model to determine effects of diet and exercise on cholesterol accumulation in the body. Comp Biochem Physiol. 1990;95:275-280.
48.
Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, Williams PT, Johnstone IM, Champagne MA, Krauss RM, Farquhar JW. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: the Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994;89:975-990.
49.
Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res. 1994;74:349-353.
50.
McLenahan JM, William JK, Fish RD, Ganz P, Selwyn AP. Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation. 1991;84:1273-1278.
51. Cooke JP, Singer AH, Tsao PS, Zera P, Rowan RA, Billingham ME. Anti-atherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
52. Wang B, Singer A, Tsao P, Drexler H, Kosek J, Cooke JP. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J Am Coll Cardiol. 1994;23:452-458.[Abstract]
53.
Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation. 1994;89:2176-2182.
54.
Cayette AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14:753-759.
55.
Naruse K, Shimizu K, Muramatsu M, Toki Y, Miyazaki Y, Okumura K, Hashimoto H, Ito T. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta: PGH2 does not contribute to impaired endothelium-dependent relaxation. Arterioscler Thromb. 1994;14:746-752.
56.
Lefer AM, Ma XL. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb. 1993;13:771-776.
This article has been cited by other articles:
 |
|
 |
|
  N. Singhania, D. Puri, S.V. Madhu, and S.B. Sharma Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy QJM, June 1, 2008; 101(6): 449 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lee, J. Chung, I. S. Ha, K. Yi, J. E. Lee, H. G. Kang, I. Choi, K.-H. Oh, J. Y. Kim, C. D. Surh, et al. Hydrogen peroxide increases human leukocyte adhesion to porcine aortic endothelial cells via NF{kappa}B-dependent up-regulation of VCAM-1 Int. Immunol., December 1, 2007; 19(12): 1349 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Won, S.-N. Zhu, M. Chen, A.-M. Teichert, J. E. Fish, C. C. Matouk, M. Bonert, M. Ojha, P. A. Marsden, and M. I. Cybulsky Relative Reduction of Endothelial Nitric-Oxide Synthase Expression and Transcription in Atherosclerosis-Prone Regions of the Mouse Aorta and in an in Vitro Model of Disturbed Flow Am. J. Pathol., November 1, 2007; 171(5): 1691 - 1704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Dangaria and P. J. Butler Macrorheology and adaptive microrheology of endothelial cells subjected to fluid shear stress Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1568 - C1575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Gleissner, N. Leitinger, and K. Ley Effects of Native and Modified Low-Density Lipoproteins on Monocyte Recruitment in Atherosclerosis Hypertension, August 1, 2007; 50(2): 276 - 283. [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Lowenstein Nitric oxide regulation of protein trafficking in the cardiovascular system Cardiovasc Res, July 15, 2007; 75(2): 240 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Garin, J.-i. Abe, A. Mohan, W. Lu, C. Yan, A. C. Newby, A. Rhaman, and B. C. Berk Flow Antagonizes TNF-{alpha} Signaling in Endothelial Cells by Inhibiting Caspase-Dependent PKC{zeta} Processing Circ. Res., July 6, 2007; 101(1): 97 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, S. Pan, and B. C. Berk Glutaredoxin Mediates Akt and eNOS Activation by Flow in a Glutathione Reductase-Dependent Manner Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1283 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Liao Secondary Prevention of Stroke and Transient Ischemic Attack: Is More Platelet Inhibition the Answer? Circulation, March 27, 2007; 115(12): 1615 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Duerrschmidt, C. Stielow, G. Muller, P. J. Pagano, and H. Morawietz NO-mediated regulation of NAD(P)H oxidase by laminar shear stress in human endothelial cells J. Physiol., October 15, 2006; 576(2): 557 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhang, R. Lopez-Ridaura, D. J. Hunter, N. Rifai, and F. B. Hu Common variants of the endothelial nitric oxide synthase gene and the risk of coronary heart disease among u.s. Diabetic men. Diabetes, July 1, 2006; 55(7): 2140 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, Y. Zhang, K. Schmelzer, T.-S. Lee, X. Fang, Y. Zhu, A. A. Spector, S. Gill, C. Morisseau, B. D. Hammock, et al. The antiinflammatory effect of laminar flow: The role of PPAR{gamma}, epoxyeicosatrienoic acids, and soluble epoxide hydrolase PNAS, November 15, 2005; 102(46): 16747 - 16752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. C. Mehra, V. S. Ramgolam, and J. R. Bender Cytokines and cardiovascular disease J. Leukoc. Biol., October 1, 2005; 78(4): 805 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Chacko, R. T. Chandler, A. Mundhekar, N. Khoo, H. M. Pruitt, D. F. Kucik, D. A. Parks, C. G. Kevil, S. Barnes, and R. P. Patel Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H908 - H915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P Cooke ADMA: its role in vascular disease Vascular Medicine, July 1, 2005; 10(1_suppl): S11 - S17. [Abstract] [PDF]
|
|
|
|
|
|
J. P Cooke ADMA: its role in vascular disease Vascular Medicine, May 1, 2005; 10(2_suppl): S11 - S17. [Abstract] [PDF]
|
|
|
|
 |
|
 Z.-G. Jin, C. Wong, J. Wu, and B. C. Berk Flow Shear Stress Stimulates Gab1 Tyrosine Phosphorylation to Mediate Protein Kinase B and Endothelial Nitric-oxide Synthase Activation in Endothelial Cells J. Biol. Chem., April 1, 2005; 280(13): 12305 - 12309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Khmelewski, A. Becker, T. Meinertz, and W. D. Ito Tissue Resident Cells Play a Dominant Role in Arteriogenesis and Concomitant Macrophage Accumulation Circ. Res., September 17, 2004; 95(6): e56 - e64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, Y. Zhu, F. Rannou, T.-S. Lee, K. Formentin, L. Zeng, X. Yuan, N. Wang, S. Chien, B. M. Forman, et al. Laminar Flow Activates Peroxisome Proliferator-Activated Receptor-{gamma} in Vascular Endothelial Cells Circulation, August 31, 2004; 110(9): 1128 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Kuhlencordt, E. Rosel, R. E. Gerszten, M. Morales-Ruiz, D. Dombkowski, W. J. Atkinson, F. Han, F. Preffer, A. Rosenzweig, W. C. Sessa, et al. Role of endothelial nitric oxide synthase in endothelial activation: insights from eNOS knockout endothelial cells Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1195 - C1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-J. Chiu, P.-L. Lee, C.-N. Chen, C.-I Lee, S.-F. Chang, L.-J. Chen, S.-C. Lien, Y.-C. Ko, S. Usami, and S. Chien Shear Stress Increases ICAM-1 and Decreases VCAM-1 and E-selectin Expressions Induced by Tumor Necrosis Factor-{alpha} in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 73 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Dayoub, V. Achan, S. Adimoolam, J. Jacobi, M. C. Stuehlinger, B.-y. Wang, P. S. Tsao, M. Kimoto, P. Vallance, A. J. Patterson, et al. Dimethylarginine Dimethylaminohydrolase Regulates Nitric Oxide Synthesis: Genetic and Physiological Evidence Circulation, December 16, 2003; 108(24): 3042 - 3047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Pilz and D. E. Casteel Regulation of Gene Expression by Cyclic GMP Circ. Res., November 28, 2003; 93(11): 1034 - 1046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hwang, A. Saha, Y. C. Boo, G. P. Sorescu, J. S. McNally, S. M. Holland, S. Dikalov, D. P. Giddens, K. K. Griendling, D. G. Harrison, et al. Oscillatory Shear Stress Stimulates Endothelial Production of O2- from p47phox-dependent NAD(P)H Oxidases, Leading to Monocyte Adhesion J. Biol. Chem., November 21, 2003; 278(47): 47291 - 47298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yamawaki, S. Lehoux, and B. C. Berk Chronic Physiological Shear Stress Inhibits Tumor Necrosis Factor-Induced Proinflammatory Responses in Rabbit Aorta Perfused Ex Vivo Circulation, September 30, 2003; 108(13): 1619 - 1625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-L. Yang, C. J. Jen, and H.-i. Chen Effects of high-cholesterol diet and parallel exercise training on the vascular function of rabbit aortas: a time course study J Appl Physiol, September 1, 2003; 95(3): 1194 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. C. Boo and H. Jo Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases Am J Physiol Cell Physiol, September 1, 2003; 285(3): C499 - C508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Stuhlinger, R. K. Oka, E. E. Graf, I. Schmolzer, B. M. Upson, O. Kapoor, A. Szuba, M. R. Malinow, T. C. Wascher, O. Pachinger, et al. Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia: Role of Asymmetric Dimethylarginine Circulation, August 26, 2003; 108(8): 933 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-G. Jin, H. Ueba, T. Tanimoto, A. O. Lungu, M. D. Frame, and B. C. Berk Ligand-Independent Activation of Vascular Endothelial Growth Factor Receptor 2 by Fluid Shear Stress Regulates Activation of Endothelial Nitric Oxide Synthase Circ. Res., August 22, 2003; 93(4): 354 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Niebauer, A. J. Maxwell, P. S. Lin, D. Wang, P. S. Tsao, and J. P. Cooke NOS inhibition accelerates atherogenesis: reversal by exercise Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H535 - H540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Aird The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome Blood, May 15, 2003; 101(10): 3765 - 3777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, F. Yang, X.-P. Yang, M. Jankowski, and P. J. Pagano NAD(P)H Oxidase Mediates Angiotensin II-Induced Vascular Macrophage Infiltration and Medial Hypertrophy Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 776 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Davis, H. Cai, L. McCann, T. Fukai, and D. G. Harrison Role of c-Src in regulation of endothelial nitric oxide synthase expression during exercise training Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1449 - H1453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Risnes, T. Ueland, R. Lundblad, T. E. Mollnes, S. T. Baksaas, P. Aukrust, and J. L. Svennevig Changes in the cytokine network and complement parameters during open heart surgery Interactive CardioVascular and Thoracic Surgery, March 1, 2003; 2(1): 19 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Cooke Flow, NO, and atherogenesis PNAS, February 4, 2003; 100(3): 768 - 770. [Full Text] [PDF]
|
|
|
|
|
|
X.-L. Chen, S. E. Varner, A. S. Rao, J. Y. Grey, S. Thomas, C. K. Cook, M. A. Wasserman, R. M. Medford, A. K. Jaiswal, and C. Kunsch Laminar Flow Induction of Antioxidant Response Element-mediated Genes in Endothelial Cells. A NOVEL ANTI-INFLAMMATORY MECHANISM J. Biol. Chem., January 3, 2003; 278(2): 703 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Weis, C. L. Schlichting, E. G. Engleman, and J. P. Cooke Endothelial Determinants of Dendritic Cell Adhesion and Migration: New Implications for Vascular Diseases Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1817 - 1823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. C. Boo, J. Hwang, M. Sykes, B. J. Michell, B. E. Kemp, H. Lum, and H. Jo Shear stress stimulates phosphorylation of eNOS at Ser635 by a protein kinase A-dependent mechanism Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1819 - H1828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kinlay, J. Grewal, D. Manuelin, J. C. Fang, A. P. Selwyn, J. A. Bittl, and P. Ganz Coronary Flow Velocity and Disturbed Flow Predict Adverse Clinical Outcome After Coronary Angioplasty Arterioscler. Thromb. Vasc. Biol., August 1, 2002; 22(8): 1334 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nilsson, M.P.S. Ares, M. Lindholm, G.N. Fredriksonl, and S. Jovinge Inflammation and cholesterol Eur. Heart J. Suppl., February 1, 2002; 4(suppl_A): A18 - A25. [Abstract] [PDF]
|
|
|
|
|
|
Y. C. Boo, G. Sorescu, N. Boyd, I. Shiojima, K. Walsh, J. Du, and H. Jo Shear Stress Stimulates Phosphorylation of Endothelial Nitric-oxide Synthase at Ser1179 by Akt-independent Mechanisms. ROLE OF PROTEIN KINASE A J. Biol. Chem., January 25, 2002; 277(5): 3388 - 3396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Hsiai, S. K. Cho, S. Reddy, S. Hama, M. Navab, L. L. Demer, H. M. Honda, and C. M. Ho Pulsatile Flow Regulates Monocyte Adhesion to Oxidized Lipid-Induced Endothelial Cells Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1770 - 1776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Tarpey and I. Fridovich Methods of Detection of Vascular Reactive Species: Nitric Oxide, Superoxide, Hydrogen Peroxide, and Peroxynitrite Circ. Res., August 3, 2001; 89(3): 224 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Osanai, N. Akutsu, N. Fujita, T. Nakano, K. Takahashi, W. Guan, and K. Okumura Cross talk between prostacyclin and nitric oxide under shear in smooth muscle cell: role in monocyte adhesion Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H177 - H182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Cooke and P. S. Tsao Go With the Flow Circulation, June 12, 2001; 103(23): 2773 - 2775. [Full Text] [PDF]
|
|
|
|
 |
|
 A. A Brown and F. B Hu Dietary modulation of endothelial function: implications for cardiovascular disease Am. J. Clinical Nutrition, April 1, 2001; 73(4): 673 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Boger, S. M. Bode-Boger, P. S. Tsao, P. S. Lin, J. R. Chan, and J. P. Cooke An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2287 - 2295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Uemura, C. G. Fathman, J. B. Rothbard, and J. P. Cooke Rapid and Efficient Vascular Transport of Arginine Polymers Inhibits Myointimal Hyperplasia Circulation, November 21, 2000; 102(21): 2629 - 2635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zampolli, G. Basta, G. Lazzerini, M. Feelisch, and R. De Caterina Inhibition of Endothelial Cell Activation by Nitric Oxide Donors J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 818 - 823. [Abstract] [Full Text]
|
|
|
|
|
|
L. Cominacini, A. F. Pasini, U. Garbin, A. Davoli, M. L. Tosetti, M. Campagnola, A. Rigoni, A. M. Pastorino, V. Lo Cascio, and T. Sawamura Oxidized Low Density Lipoprotein (ox-LDL) Binding to ox-LDL Receptor-1 in Endothelial Cells Induces the Activation of NF-kappa B through an Increased Production of Intracellular Reactive Oxygen Species J. Biol. Chem., April 21, 2000; 275(17): 12633 - 12638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Collard, A. Agah, W. Reenstra, J. Buras, and G. L. Stahl Endothelial Nuclear Factor-{kappa}B Translocation and Vascular Cell Adhesion Molecule-1 Induction by Complement : Inhibition With Anti-Human C5 Therapy or cGMP Analogues Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2623 - 2629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Niebauer, S. P. Schwarzacher, M. Hayase, B. Wang, R. S. Kernoff, J. P. Cooke, and A. C. Yeung Local L-Arginine Delivery After Balloon Angioplasty Reduces Monocyte Binding and Induces Apoptosis Circulation, October 26, 1999; 100(17): 1830 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kunsch and R. M. Medford Oxidative Stress as a Regulator of Gene Expression in the Vasculature Circ. Res., October 15, 1999; 85(8): 753 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Niebauer, J.o. Dulak, J. R. Chan, P. S. Tsao, and J. P. Cooke Gene transfer of nitric oxide synthase: Effects on endothelial biology J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1201 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Rosolowsky, C. J. Hanke, and W. B. Campbell Adrenal Capillary Endothelial Cells Stimulate Aldosterone Release through a Protein That Is Distinct from Endothelin Endocrinology, October 1, 1999; 140(10): 4411 - 4418. [Abstract] [Full Text]
|
|
|
|
|
|
M. M. Tarpey, C. R. White, E. Suarez, G. Richardson, R. Radi, and B. A. Freeman Chemiluminescent Detection of Oxidants in Vascular Tissue : Lucigenin But Not Coelenterazine Enhances Superoxide Formation Circ. Res., May 28, 1999; 84(10): 1203 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P Cooke The 1998 Nobel prize in Medicine: clinical implications for 1999 and beyond Vascular Medicine, May 1, 1999; 4(2): 57 - 60. [PDF]
|
|
|
|
|
|
P. Clarkson, H. E. Montgomery, M. J. Mullen, A. E. Donald, A. J. Powe, T. Bull, M. Jubb, M. World, and J. E. Deanfield Exercise training enhances endothelial function in young men J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1379 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Miyazaki, H. Matsuoka, J. P. Cooke, M. Usui, S. Ueda, S. Okuda, and T. Imaizumi Endogenous Nitric Oxide Synthase Inhibitor : A Novel Marker of Atherosclerosis Circulation, March 9, 1999; 99(9): 1141 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dimmeler, C. Hermann, J. Galle, and A. M. Zeiher Upregulation of Superoxide Dismutase and Nitric Oxide Synthase Mediates the Apoptosis-Suppressive Effects of Shear Stress on Endothelial Cells Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 656 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Corseaux, T. Le Tourneau, I. Six, M. D. Ezekowitz, E. P. Mc Fadden, T. Meurice, P. Asseman, C. Bauters, and B. Jude Enhanced Monocyte Tissue Factor Response After Experimental Balloon Angioplasty in Hypercholesterolemic Rabbit: Inhibition With Dietary L-Arginine Circulation, October 27, 1998; 98(17): 1776 - 1782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dimmeler, B. Assmus, C. Hermann, J. Haendeler, and A. M. Zeiher Fluid Shear Stress Stimulates Phosphorylation of Akt in Human Endothelial Cells : Involvement in Suppression of Apoptosis Circ. Res., August 10, 1998; 83(3): 334 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Oemar, M. R. Tschudi, N. Godoy, V. Brovkovich, T. Malinski, and T. F. Luscher Reduced Endothelial Nitric Oxide Synthase Expression and Production in Human Atherosclerosis Circulation, June 30, 1998; 97(25): 2494 - 2498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Calara, P. Dimayuga, A. Niemann, J. Thyberg, U. Diczfalusy, J. L. Witztum, W. Palinski, P. K. Shah, B. Cercek, J. Nilsson, et al. An Animal Model to Study Local Oxidation of LDL and Its Biological Effects in the Arterial Wall Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 884 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. De Keulenaer, D. C. Chappell, N. Ishizaka, R. M. Nerem, R. W. Alexander, and K. K. Griendling Oscillatory and Steady Laminar Shear Stress Differentially Affect Human Endothelial Redox State : Role of a Superoxide-Producing NADH Oxidase Circ. Res., June 1, 1998; 82(10): 1094 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Cines, E. S. Pollak, C. A. Buck, J. Loscalzo, G. A. Zimmerman, R. P. McEver, J. S. Pober, T. M. Wick, B. A. Konkle, B. S. Schwartz, et al. Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders Blood, May 15, 1998; 91(10): 3527 - 3561. [Full Text] [PDF]
|
|
|
|
|
|
J.J. Chiu, B.S. Wung, J. Y.J. Shyy, H.J. Hsieh, and D.L. Wang Reactive Oxygen Species Are Involved in Shear Stress-Induced Intercellular Adhesion Molecule-1 Expression in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3570 - 3577. [Abstract] [Full Text]
|
|
|
|
|
|
J. Niebauer, R. Hambrecht, T. Velich, K. Hauer, C. Marburger, B. Kalberer, C. Weiss, E. von Hodenberg, G. Schlierf, G. Schuler, et al. Attenuated Progression of Coronary Artery Disease After 6 Years of Multifactorial Risk Intervention : Role of Physical Exercise Circulation, October 21, 1997; 96(8): 2534 - 2541. [Abstract] [Full Text]
|
|
|
|
|
|
W. D. Ito, M. Arras, B. Winkler, D. Scholz, J. Schaper, and W. Schaper Monocyte Chemotactic Protein-1 Increases Collateral and Peripheral Conductance After Femoral Artery Occlusion Circ. Res., June 19, 1997; 80(6): 829 - 837. [Abstract] [Full Text]
|
|
|
|
|
|
J. Surapisitchat, R. J. Hoefen, X. Pi, M. Yoshizumi, C. Yan, and B. C. Berk Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members PNAS, May 22, 2001; 98(11): 6476 - 6481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Matsushita, E. Chang, A. J. Glassford, J. P. Cooke, C.-P. Chiu, and P. S. Tsao eNOS Activity Is Reduced in Senescent Human Endothelial Cells: Preservation by hTERT Immortalization Circ. Res., October 26, 2001; 89(9): 793 - 798. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||